References
- SunCLeeJSZhangMMagnetic nanoparticles in MR imaging and drug deliveryAdv Drug Deliv Rev2008601252126518558452
- McBainSCYiuHHDobsonJMagnetic nanoparticles for gene and drug deliveryInt J Nanomedicine2008316918018686777
- MahCFraitesTJZolotukhinIImproved method of recombinant AAV2 delivery for systemic targeted gene therapyMol Ther2002610611212095310
- NamgungRSinghaKHybrid superparamagnetic iron oxide nanoparticle-branched polyethylenimine magnetoplexes for gene transfection of vascular endothelial cellsBiomaterials2010314204421320170956
- PanXGuanbJYoodJWEpsteinAJLeeLJLeeRJCationic lipid-coated magnetic nanoparticles associated with transferrin for gene deliveryInt J Pharm200835826327018384982
- SchererFAntonMSchillingerUMagnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivoGene Ther2002910210911857068
- BoyerCWhittakerMRBulmusVLiuJDavisTPThe design and utility of polymer-stabilized iron-oxide nanoparticles for nanomedicine applicationsNPG Asia Materials201022330
- SamadikhahHRMajidiANikkhahMHosseinkhaniSPreparation, characterization, and efficient transfection of cationic liposomes and nanomagnetic cationic liposomesInt J Nanomedicine201162275228322072865
- RajDDavidoffAMNathwaniACSelf-complementary adeno-associated viral vectors for gene therapy of hemophilia B: progress and challengesExpert Rev Hematol2011453954921939421
- WeiQHuangXLLinJYFeiYJLiuZXZhangXAAdeno associated viral vector-delivered and hypoxia response element-regulated CD151 expression in ischemic rat heartActa Pharmacol Sin20113220120821240296
- WangCRShiauALChenSYIntra-articular lentivirus-mediated delivery of galectin-3 shRNA and galectin-1 gene ameliorates collagen-induced arthritisGene Ther2010171225123320520649
- BergenJMParkIKHornerPJPunSHNonviral approaches for neuronal delivery of nucleic acidsPharm Res20072598399817932730
- HudryEDamDVKulikWAdeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of alzheimer’s diseaseMol Ther201018445319654569
- JansonCMcPheeSHaselgroveJClinical protocol. Gene therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brainHum Gene Ther2002131391141212162821
- KunzeMHuberAKrajewskiAEfficient gene transfer to periodontal ligament cells and human gingival fibroblasts by adeno-associated virus vectorsJ Dent20093750250819362764
- ZhangYSchlachetzkiFZhangYFBoadoRJPardridgeWMNormalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism with intravenous nonviral gene therapy and a brain-specific promoterHum Gene Ther20041533935015053859
- KwonEJLasieneJJacobsonBEParkIKHornerPJPunSHTargeted nonviral delivery vehicles to neural progenitor cells in the mouse subventricular zoneBiomaterials2010312417242420004466
- ZhangXBeaulieuJMSotnikovaTDGainetdinovRRCaronMGTryptophan hydroxylase-2 controls brain serotonin synthesisScience200430521715247473
- TencomnaoTRakkhitawatthanaVSukhontasingKEvaluation of a novel luciferase reporter construct: a positive control plasmid for reporter gene assayAficanr Journal of Biotechnology200871321242127
- PimphaNChaleawlert-UmponSSunintaboonPCore/shell polymethyl methacrylate/polyethyleneimine particles incorporating large amounts of iron oxide nanoparticles prepared by emulsifier-free emulsion polymerizationPolymer20125320152022
- BalázsNSiposPLimitations of pH-potentiometric titration for the determination of the degree of deacetylation of chitosanCarbohydr Res200734212413017145045
- DivyaCSPillaiMRAntitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosisMol Carcinog20064532033216526022